ストックスクリーナーアプリを入手
9.08
1.11%
0.10
アフターアワーズ：
9.24
0.16
+1.76%
前日終値:
$8.98
開ける：
$9.02
24時間の取引高:
304.40K
Relative Volume:
0.53
時価総額：
$368.96M
収益：
$324.01M
当期純損益:
$-192.37M
株価収益率:
-1.8996
EPS:
-4.78
ネットキャッシュフロー:
$-23.46M
1週間 パフォーマンス:
+1.91%
1か月 パフォーマンス:
+27.89%
6か月 パフォーマンス:
+59.86%
1年 パフォーマンス:
+17.46%
1日の値動き範囲:
$8.91
$9.12
1週間の範囲:
$8.75
$9.4004
52週間の値動き範囲:
$5.26
$9.58
Angiodynamic Inc Stock (ANGO) Company Profile
ANGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
9.08 | 368.96M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-05 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-17 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 開始されました | Oppenheimer | Perform |
| 2020-11-25 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | ダウングレード | Craig Hallum | Buy → Hold |
| 2017-04-07 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-03-30 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 開始されました | Barclays | Equal Weight |
| 2016-11-04 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-04-08 | 再開されました | Piper Jaffray | Neutral |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 繰り返されました | Canaccord Genuity | Hold |
| 2012-06-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | アップグレード | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | ダウングレード | Wedbush | Neutral → Underperform |
| 2010-09-08 | 繰り返されました | Wedbush | Neutral |
すべてを表示
Angiodynamic Inc (ANGO) 最新ニュース
Geode Capital Management LLC Boosts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Barclays PLC Has $651,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Franklin Resources Inc. - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3% - MarketBeat
State Street Corp Has $6.31 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Fmr LLC - Defense World
XTX Topco Ltd Takes $582,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics - Benzinga
There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding - Simply Wall St
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Increased by BNP Paribas Financial Markets - MarketBeat
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife - Marketscreener.com
AngioDynamics Secures FDA Clearance for Breakthrough Prostate Cancer Treatment System After Strong Trial Results - StockTitan
Jacobs Levy Equity Management Inc. Sells 95,157 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics Port Defect Caused Infection, Ga. Man Says - Law360
Systematic Financial Management LP Has $18.75 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Segall Bryant & Hamill LLC Has $7.09 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
NeuroOne Medical Technologies (NASDAQ:NMTC) and AngioDynamics (NASDAQ:ANGO) Critical Review - Defense World
Royce & Associates LP Has $7.67 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
AngioDynamics Shareholder Approvals and Director Elections - TipRanks
Wealth Enhancement Advisory Services LLC Buys New Shares in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
AngioDynamics (NASDAQ:ANGO) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? - MSN
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade - Yahoo Finance
AngioDynamics staying in Queensbury after all. Leaders cite changed business model. - The Post Star
Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years - Yahoo Finance
SG Americas Securities LLC Invests $103,000 in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 31.0% - MarketBeat
Cwm LLC Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Here's Why You Should Add AngioDynamics Stock to Your Portfolio - MSN
AngioDynamics (NASDAQ:ANGO) adds US$30m to market cap in the past 7 days, though investors from three years ago are still down 75% - Simply Wall St
AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System - StockTitan
AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments - Medical Device Network
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver - StockTitan
AngioDynamics secures new CPT codes for NanoKnife System - Investing.com
Angiodynamic Inc (ANGO)’s stock decline to 6.33 per share - US Post News
AngioDynamics Xcela Port Catheter Problems Caused Sepsis Infection, Lawsuit Claims - AboutLawsuits.com
Its Stock Has Paid Off Big Time For Angiodynamic Inc - SETE News
Angel One Profits Jump 39% Thanks To Trading Boom - Finimize
A Guide To The Risks Of Investing In Angiodynamic Inc (ANGO) - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Decrease in Short Interest - MarketBeat
Insider Buying: Nighan Warren JR, Angiodynamic Inc [ANGO] SVP Quality and Regulatory invested 768 shares - Knox Daily
Study Begins For AngioDynamics' AlphaVac F18⁸⁵ System - MPO-mag
Perrigo Company plc [PRGO] Records 50-Day SMA of $27.19 - Knox Daily
Marshall Wace LLP Sells 218,500 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AQR Capital Management LLC Sells 95,983 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Mackenzie Financial Corp Acquires Shares of 13,270 AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
3 Stocks Insiders Are Buying Heavily in October and Why - Investing.com
The Angiodynamic Inc (ANGO) had a good session last reading, didn’t it? - US Post News
Angiodynamic Inc (ANGO) 財務データ
収益
当期純利益
現金流量
EPS
Angiodynamic Inc (ANGO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nighan Warren JR | SVP Quality and Regulatory |
Oct 10 '24 |
Buy |
6.08 |
100 |
608 |
45,877 |
| Trowbridge Stephen A | EVP and CFO |
Oct 08 '24 |
Buy |
5.86 |
1,700 |
9,962 |
172,711 |
| Clemmer James C | President and CEO |
Oct 07 '24 |
Buy |
6.03 |
20,000 |
120,600 |
681,582 |
| Piccinini Laura | SVP International |
Jul 17 '24 |
Option Exercise |
0.00 |
4,439 |
0 |
42,491 |
| Clemmer James C | President and CEO |
Jul 17 '24 |
Option Exercise |
0.00 |
56,279 |
0 |
690,312 |
| Nighan Warren JR | SVP Quality and Regulatory |
Jul 17 '24 |
Option Exercise |
0.00 |
5,677 |
0 |
46,675 |
| Campbell Chad Thomas | SVP/GM, Vascular Access |
Jul 17 '24 |
Option Exercise |
0.00 |
6,600 |
0 |
70,187 |
| Trowbridge Stephen A | EVP and CFO |
Jul 17 '24 |
Option Exercise |
0.00 |
11,142 |
0 |
177,612 |
| Clemmer James C | President and CEO |
Apr 08 '24 |
Buy |
6.70 |
10,000 |
67,000 |
539,066 |
2.64%
0.11%
大文字化:
|
ボリューム (24 時間):